… drugs on the clinical outcome in severe influenza. This review provides an update on the
potential role of different immuno-modulatory agents and other … with severe influenza with a …

… of treating influenza patients with statins and other immunomodulatory agents. I start with
an account of its genesis in the experience of statin treatment of patients with acute coronary …

… Several other immunomodulatory agents are being assessed for their efficacy, both in vitro
and in vivo. Lin and colleagues 58 have confirmed that CCR inhibitor-treated mice had a …

… This article reviews the potential role of adjunctive therapies and immunomodulating
agents in the management of patients hospitalized with severe influenza and other acute …

… More animal experiments and detailed human observational studies and (where feasible)
RCTs are needed to evaluate the efficacy of other agents with potential immunomodulatory …

… guidelines do not recommend any immunomodulatory therapies as adjunctive treatments.3 …
on immunomodulatory agents other than corticosteroids for the treatment of severe influenza. …

… -8, IL-10, IL-6, IFN-γ, TNF, MIP-1α and soluble IL-2, were elevated compared with other
influenza strains. … This review will focus on immunomodulatory agents for the treatment of severe …

… and immunomodulatory agents along with an antiviral agent was … In other models of acute
lung injury, COX-2 inhibition actually … Another report has compared survival rates of mice …

… However, the many complexities and nuances of disease pathogenesis during severe
influenza, as well as interactions with other conditions, remain a challenge to our deep …

… An obvious strategy to optimise antiviral therapy is to combine drugs with different modes of
… therapy and of combined antiviral-immunomodulator therapy for influenza. Early-stage data …